Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.
暂无分享,去创建一个
G. Limongelli | P. Calabrò | A. Molino | G. Salerno | R. Gravino | G. Pacileo | D. Masarone | A. Rago | E. Ammendola | M. Rubino | Tommaso Marrazzo
[1] G. Limongelli,et al. Management of Arrhythmias in Heart Failure , 2017, Journal of cardiovascular development and disease.
[2] G. Limongelli,et al. Mitochondrial disease and the heart , 2016, Heart.
[3] J. Bartunek,et al. Myocarditis in Clinical Practice. , 2016, Mayo Clinic proceedings.
[4] S. Wung. Bradyarrhythmias: Clinical Presentation, Diagnosis, and Management. , 2016, Critical care nursing clinics of North America.
[5] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[6] H. Yoo,et al. Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes , 2016, Journal of Human Genetics.
[7] R. Furlan,et al. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. , 2016, The Cochrane database of systematic reviews.
[8] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[9] J. Finsterer,et al. Sudden cardiac death in neuromuscular disorders. , 2016, International journal of cardiology.
[10] Roger D. White,et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2015, Circulation.
[11] D. Montaigne,et al. Mitochondrial cardiomyopathy and related arrhythmias. , 2015, Cardiac electrophysiology clinics.
[12] M. Judson,et al. Pathophysiology and clinical management of cardiac sarcoidosis , 2015, Nature Reviews Cardiology.
[13] T. Vera. Respuesta al ECG de febrero de 2015 , 2015 .
[14] Álvaro García Ropero,et al. Cardiac amyloidosis and pacemakers: could devices delay diagnosis? , 2015 .
[15] Á. A. Navarro,et al. Amiloidosis cardiaca y marcapasos: ¿los dispositivos podrían retrasar el diagnóstico? , 2015 .
[16] C. Albert,et al. Ventricular Tachycardia in Cardiac Sarcoidosis: Characterization of Ventricular Substrate and Outcomes of Catheter Ablation , 2015, Circulation. Arrhythmia and electrophysiology.
[17] M. Boyett,et al. Biology of the Sinus Node and its Disease. , 2014, Arrhythmia & electrophysiology review.
[18] Amit R. Patel,et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.
[19] J. Kalman,et al. Fibrosis, Electrics and Genetics , 2014 .
[20] Matthew Dare,et al. Heart Rhythm Society Expert Consensus Statement on Electrophysiology Laboratory Standards: Process, Protocols, Equipment, Personnel, and Safety , 2014, Heart Rhythm.
[21] A. Prasse,et al. Sarcoidosis , 2014, The Lancet.
[22] R. D'Alessandro,et al. Skeletal muscle involvement in cardiomyopathies , 2013, Journal of Cardiovascular Medicine.
[23] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[24] J. Daubert,et al. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. , 2013, Archives of cardiovascular diseases.
[25] Y. Pinto,et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[26] G. Bonne,et al. ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.
[27] S. Barra,et al. A Review on Advanced Atrioventricular Block in Young or Middle‐Aged Adults , 2012, Pacing and clinical electrophysiology : PACE.
[28] W. Groh. Arrhythmias in the muscular dystrophies. , 2012, Heart rhythm.
[29] M. Link,et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. , 2012, Circulation.
[30] D. Chemla,et al. Prophylactic pacemaker implantation in familial amyloid polyneuropathy. , 2012, Heart rhythm.
[31] G. Breithardt,et al. Bradyarrhythmias and conduction blocks. , 2012, Revista espanola de cardiologia.
[32] J. Finsterer,et al. Arrhythmia-related workup in hereditary myopathies. , 2012, Journal of electrocardiology.
[33] G. Breithardt,et al. Bradyarrhythmias and conduction blocks. , 2012 .
[34] U. Sechtem,et al. Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy , 2012, Heart.
[35] A. Zwinderman,et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.
[36] P. Elliott,et al. Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[37] M. Boyett,et al. Ageing‐dependent remodelling of ion channel and Ca2+ clock genes underlying sino‐atrial node pacemaking , 2011, Experimental physiology.
[38] M. Kupari,et al. Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults , 2011, Circulation. Arrhythmia and electrophysiology.
[39] Y. Pinto,et al. Hereditary muscular dystrophies and the heart , 2010, Neuromuscular Disorders.
[40] F. Salvi,et al. Transthyretin-related amyloidoses and the heart: a clinical overview , 2010, Nature Reviews Cardiology.
[41] J. Zamorano,et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. , 2007, European heart journal.
[42] Robert H. Anderson,et al. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. , 2007, Circulation.
[43] S. Ellard,et al. The laminopathies: a clinical review , 2006, Clinical genetics.
[44] F. Tesson,et al. Lamin A/C and cardiac diseases , 2006, Current opinion in cardiology.
[45] F. Prinzen,et al. A new paradigm for physiologic ventricular pacing. , 2006, Journal of the American College of Cardiology.
[46] R. Falk. Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.
[47] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[48] D. Garboczi,et al. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. , 2004, Journal of molecular biology.
[49] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[50] T. Cohen,et al. Complete heart block due to lyme carditis. , 2003, The Journal of invasive cardiology.
[51] L. Crown,et al. Diagnosis and treatment of sick sinus syndrome. , 2003, American family physician.
[52] L. Bindoff. Mitochondria and the heart. , 2003, European heart journal.
[53] M. Silka,et al. The Clinical Course of Acquired Complete Heart Block in Children with Acute Myocarditis , 2003, Pediatric Cardiology.
[54] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[55] M. Brignole,et al. Sick sinus syndrome. , 2002, Clinics in geriatric medicine.
[56] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[57] W. Stevenson,et al. Management of Arrhythmias in Heart Failure , 2002, Congestive heart failure.
[58] P. Vardas,et al. Sinus Pacemaker Function after Cardioversion of Chronic Atrial Fibrillation: Is Sinus Node Remodeling Related with Recurrence? , 2001, Journal of cardiovascular electrophysiology.
[59] A. Natale,et al. Congestive Heart Failure Treatment: The Pacing Approach , 2001, Heart Failure Reviews.
[60] Joanne Eastaugh,et al. The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.
[61] Mangrum Jm,et al. The Evaluation and Management of Bradycardia , 2000 .
[62] D. Hayes,et al. Symptomatic conduction system disease in cardiac amyloidosis. , 1997, The American journal of cardiology.
[63] R. Salo,et al. Acute Hemodynamic Improvement by Pacing in Patients with Severe Congestive Heart Failure , 1997, Pacing and clinical electrophysiology : PACE.
[64] Camm Aj,et al. Sinus node disease. Current concepts in diagnosis and therapy. , 1992 .
[65] W. Stevenson,et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.
[66] W. Stanage,et al. Birth certificate data: how reliable? , 1984, South Dakota journal of medicine.
[67] C. B. Mullins,et al. Prognoses and management of venticular conduction blocks in acute myocardial infarction. , 1976, Modern concepts of cardiovascular disease.
[68] R. O'rourke. Clinical cardiology: the stokes-adams syndrome-definition and etiology; mechanisms and treatment. , 1972, California medicine.
[69] K. Smith,et al. Aetiology of Complete Heart-block , 1963, Lancet.
[70] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[71] R. D'Alessandro,et al. Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. , 2012, Future cardiology.
[72] P. Elliott,et al. Anderson-Fabry disease and the heart. , 2010, Progress in cardiovascular diseases.
[73] L. Cooper,et al. Cardiac sarcoidosis. , 2009, American heart journal.
[74] D. Hayes,et al. Second-degree atrioventricular block: a reappraisal. , 2001, Mayo Clinic proceedings.
[75] L. Newman,et al. Medical progress : Sarcoidosis , 1997 .
[76] B. Waller,et al. Anatomy, histology, and pathology of the cardiac conduction system. III , 1993 .
[77] J Ross,et al. Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. , 1988, Journal of the American College of Cardiology.
[78] D. Durrer,et al. Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. , 1980, American heart journal.